KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Construction in Progress (2016 - 2025)

Boston Scientific's Construction in Progress history spans 17 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Construction in Progress rose 12.17% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 12.17%, while the annual FY2025 figure was $1.2 billion, 12.17% up from the prior year.
  • Construction in Progress for Q4 2025 was $1.2 billion at Boston Scientific, up from $936.0 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $1.2 billion in Q4 2025 and bottomed at $418.0 million in Q1 2021.
  • The 5-year median for Construction in Progress is $648.0 million (2021), against an average of $737.6 million.
  • The largest annual shift saw Construction in Progress fell 7.11% in 2021 before it soared 55.2% in 2024.
  • A 5-year view of Construction in Progress shows it stood at $605.0 million in 2021, then fell by 1.16% to $598.0 million in 2022, then skyrocketed by 43.31% to $857.0 million in 2023, then rose by 20.77% to $1.0 billion in 2024, then rose by 12.17% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Construction in Progress are $1.2 billion (Q4 2025), $936.0 million (Q3 2025), and $1.0 billion (Q2 2025).